Here are five highlights:
1. In seven years, Medicare spending on the EpiPen increased 1,151 percent.
2. The number of EpiPen users rallied 164 percent from 2007 to 2014.
3. Medicare spent $7 million on EpiPen in 2007 for 79,980 users in 2007.
4. That figure increased to $87.9 million in 2014.
5. In 2014, nearly 211,500 Medicare members used EpiPen.
More articles on coding & billing:
3 legislative changes impacting ASCs — Sept. 21, 2016
Sen. Bernie Sanders and others leading campaign to offer public option on ACA: 5 things to know
Connecticut’s Insurance Commissioner withdrawing from Anthem-Cigna review: 7 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.